ABBOTT INDIA
Back to Income Statement
|
ABBOTT INDIA Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹6,409 Cr | ₹5,849 Cr | ₹5,349 Cr | ₹4,913 Cr | ₹4,310 Cr |
What is the latest Revenue of ABBOTT INDIA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹6,409 Cr |
| Mar2024 | ₹5,849 Cr |
| Mar2023 | ₹5,349 Cr |
| Mar2022 | ₹4,913 Cr |
| Mar2021 | ₹4,310 Cr |
How is Revenue of ABBOTT INDIA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,409 Cr | 9.58 | |
| Mar2024 | ₹5,849 Cr | 9.35 | |
| Mar2023 | ₹5,349 Cr | 8.86 | |
| Mar2022 | ₹4,913 Cr | 14.00 | |
| Mar2021 | ₹4,310 Cr | - | |
Compare Revenue of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹60,439.5 Cr | 0.6% | -5.2% | 1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 0.6% |
-5.2% |
1% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses